Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma have?
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma has 6 citations in the OpenAlex counts ScholarIQ stores.
When was Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma published?
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma has 2019 year in the ScholarIQ index.
What is the open-access status of Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma?
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma?
The DOI for Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma is on the source record.
What is the PMID of Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma?
The PMID for Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma is on the source record.
What is the OpenAlex record for Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma?
The OpenAlex for Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma is on the source record.